Touro Scholar
COVID-19 Newsletter

NYMC Publications

10-12-2022

COVID-19 Newsletter (Vol. 140)
Center for Disaster Medicine, New York Medical College

Follow this and additional works at: https://touroscholar.touro.edu/nymc_covid19_newsletter
Part of the Infectious Disease Commons, Influenza Humans Commons, and the Virus Diseases
Commons

From:
To:
Subject:
Date:
Attachments:

NYMC_COVID19Newsletter on behalf of Disaster Medicine
NYMC_COVID19NEWSLETTER@LISTSERV.TOURO.EDU
Center for Disaster Medicine Information Brief
Wednesday, October 12, 2022 3:00:14 PM
image003.png
image001.png

Wednesday, October 12, 2022
As the COVID-19 pandemic continues to evolve, we are seeing other emerging public health threats/emergencies and we continue to address
ongoing/emerging disaster issues, the Center for Disaster Medicine (CDM) has been and will continue to be a source of reliable information, education
and models for mitigation, preparedness, response, and recovery. As such we have expanded this informational document to address the broader areas
addressed by the center while retaining critical COVID19 information. As the pace of new information and changes occur, we will evaluate the current
once per week to determine if this information should be provided on a more frequent basis

                                                                                                                       
David Markenson, M.D., M.B.A.
Director, Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

622,602,924

6,560,508

9,063,791,250

United States

96,772,268

1,063,310

611,686,655

New Jersey

2,759,767

34,792

18,506,887

New York

6,157,936

71,986

41,982,057

Connecticut

902,374

11,385

8,267,573

Information as of 10/12/22 at 0900 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Money Pox Statistics
State

Number of Cases

Connecticut

132

New Jersey

727

New York

4010

Total US Case Count

26778

CDC https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html

Center for Disaster Medicine Updates
Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continuing to partner with local organizations such as Westchester Department of Emergency Services and Westchester Medical
Center to ensure ongoing collaboration with all public safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify strengths and areas for improvement in
other regions.
Updating and developing new programs to provide enhanced education on public health emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline responders in the hospital and in the
field.
Serving as a source of information for COVID-19 related concerns or questions regarding public health, emergency medical service
(EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using first-person
experiences to highlight current trends.

                                      

The White House
On October 11, 2022, Press Secretary Karine Jean-Pierre and Covid-19 Response Coordinator Dr.
Ashish Jha provided a press briefing regarding COVID-19 response. They discussed the benefits of
the updated vaccines and new vaccines and our work to ensure that all eligible Americans do get
vaccinated ahead of the winter.
https://www.whitehouse.gov/briefing-room/press-briefings/2022/10/11/press-briefing-by-presssecretary-karine-jean-pierre-and-covid-19-response-coordinator-dr-ashish-jha-5/
The official website of the White House will deliver updated information as the country grapples

with converging crises. This will include actions to control the COVID-19 pandemic and monkeypox
and provide economic relief, tackle climate change, and advance racial equity and civil rights, as
well as immediate actions to reform our immigration system and restore America’s standing in the
world. This website will provide all information in one central location.
https://www.whitehouse.gov

COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website was
launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/

Health and Human Services (HHS)
On October 7, 2022, HHS released a report showing COVID-19 Vaccinations in 2021 Linked to
More than 650,000 Fewer COVID-19 Hospitalizations and Over 300,000 Fewer Deaths Among
Medicare Beneficiaries, Underscoring Importance of Getting Updated COVID-19 Vaccines This
Fall. https://www.hhs.gov/about/news/2022/10/07/new-hhs-report-covid-19-vaccinations-in-2021linked-to-more-than-650000-fewer-covid-19-hospitalizations.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
On October 6, 2022, the NIH released a report revealing findings from a small study of eight
patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not
caused by impaired immune responses. The study, led by scientists at the National Institute of
Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aimed to define
the clinical course and the immunologic and virologic characteristics of COVID-19 rebound in
patients who have taken nirmatrelvir/ritonavir (Paxlovid), an antiviral therapeutic developed by
Pfizer, Inc. COVID-19 rebound is characterized by a recurrence of COVID-19 symptoms and/or a
new positive viral test after having tested negative, according to the Centers for Disease Control
and Prevention. According to the study authors, the results do not support the hypothesis that the
five-day course of Paxlovid is too short for the body to develop a strong immune response to
SARS-CoV-2, the virus that causes COVID-19.
https://www.nih.gov/news-events/findings-suggest-covid-19-rebound-not-caused-impaired-immuneresponse
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

Centers for Disease Control and Prevention (CDC)        
Monkeypox is a rare disease caused by infection with the monkeypox virus.
Monkeypox virus is part of the same family of viruses as variola virus, the virus that
causes smallpox. Monkeypox symptoms are like smallpox symptoms, but milder, and
monkeypox is rarely fatal. Monkeypox is not related to chickenpox.
For the latest CDC information including symptoms, testing, vaccines and prevention
regarding monkeypox, please visit
https://www.cdc.gov/poxvirus/monkeypox/
According to the CDC, as of October 11, 2022, there are 26,778 cases in the United
States. For the latest monkeypox cases in the United States, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html
According to the CDC, as of October 11, 2022, there are 71,408 cases in the world.
For the latest global monkeypox cases, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
On October 11, 2022, the CDC updated the monkeypox section regarding the latest
information on signs and symptoms, vaccines, prevention, sexual health, cases and
data.
https://www.cdc.gov/poxvirus/monkeypox/index.html
On October 7, 2022, the CDC released Interim Clinical Considerations for
Management of Ocular Monkeypox Virus Infection for healthcare providers who
provide care to patients with monkeypox.
https://www.cdc.gov/poxvirus/monkeypox/clinicians/ocular-infection.html

On October 4, 2022, the CDC released Clinical Considerations for Monkeypox in
Children and Adolescents for providers caring for children and adolescents less than
ages 18 years in clinics, emergency departments, and hospitals in the United States.
https://www.cdc.gov/poxvirus/monkeypox/clinicians/pediatric.html
CDC provides updated information about the variants in the United States- The
emerging variants CDC is closely monitoring have mutations in the virus genome that
alter the characteristics and cause the virus to act differently in ways that are
significant to public health (e.g., causes more severe disease, spreads more easily
between humans, requires different treatments, changes the effectiveness of current
vaccines). It’s important to understand that genetic mutations are expected, and
some variants can spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
On October 11, 2022, the CDC provided an update regarding COVID-19 Vaccines for
People Who Are Moderately or Severely Immunocompromised.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html
On October 5, 2022, the CDC provided updated guidance regarding Operational
Guidance for K-12 Schools and Early Care and Education Programs to Support Safe
In-Person Learning- Schools and early care and education (ECE) programs are an
important part of the infrastructure of communities as they provide safe, supportive
learning environments for students and children and enable parents and caregivers to
be at work. Schools and ECE programs like Head Start also provide critical services
that help to mitigate health disparities, such as school lunch programs, and social,
physical, behavioral, and mental health services. This guidance can help K-12
schools and ECE programs remain open and help their administrators support safe,
in-person learning while reducing the spread of COVID-19. Based on the COVID-19
Community Levels, this guidance provides flexibility so schools and ECE programs
can adapt to changing local situations, including periods of increased community
health impacts from COVID-19.
https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12childcare-guidance.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths,
and trends of COVID-19 in the United States- updated daily by 8 pm ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

United States Food and Drug Administration (FDA)
As of October 11, 2022, 436 tests and sample collection devices are authorized by
the FDA under emergency use authorizations (EUAs). These include 299 molecular
tests and sample collection devices, 85 antibody and other immune response tests,
51 antigen tests, and 1 diagnostic breath test. There are 79 molecular authorizations
and 1 antibody authorization that can be used with home-collected samples. There is
1 EUA for a molecular prescription at-home test, 2 EUAs for antigen prescription athome tests, 19 EUAs for antigen over-the-counter (OTC) at-home tests, and 3 for
molecular OTC at-home tests. The FDA has authorized 35 antigen tests and 8
molecular tests for serial screening programs. The FDA has also authorized 1127
revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-october-112022
The FDA created a specific monkeypox response page which serves as a central
source of information regarding diagnostics, vaccines, and therapeutics. For the latest
FDA information regarding monkeypox, please visit
https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/fdamonkeypox-response
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Center for Medicare and Medicaid Services (CMS) +
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of July 19, 2022, the FDA has granted Emergency
Use Authorization (EUA) to Janssen/Johnson & Johnson for adults over 18 years and
Novavax for adults over 18 years of age and EUA for Moderna and Pfizer for children
6 months to five years. On August 26, 2022, the FDA authorized the emergency use
of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of Coronavirus
Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in individuals 12 through 17 years of age. This authorization follows
a rigorous analysis and evaluation of the safety and effectiveness data conducted by

the FDA. On August 23, 2021, the FDA granted full approval to Pfizer for adults. On
January 31, 2022, the FDA granted full approval to Moderna for adults. Now with two
vaccines with full FDA approval and three vaccines with EUA for adults and children,
the goal is to vaccinate a larger number of persons in the coming months throughout
the United States. As additional vaccines are granted EUA, information for those
vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United StatesCDC provides overall US COVID-19 Vaccine, deliveries and administration, maps,
charts, and data updated daily by 8 PM. This section represents all vaccine partners
including jurisdictional partner clinics, retail pharmacies, long-term care facilities,
Federal Emergency Management Agency and Health Resources and Services
Administration partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on
the distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the
first and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
The NYS DOH provides updated monkeypox information regarding signs and
symptoms, cases, vaccine, treatment and prevention at
https://health.ny.gov/diseases/communicable/zoonoses/monkeypox/
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to
provide updated relevant information including side effects and safety data, clinical
trials demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of January 31, 2022, the fully
FDA approved Moderna vaccine will now be known as SPIKEVAX for ages 6 months
and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/differentvaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 6 months
and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with
information to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
K-12
After several school years of COVID-19 masking and social distancing,
a more normal school year is expected — as is the threat of students
and staff catching and spreading more typical illnesses like the flu and
common cold. Health experts advise schools to be vigilant about
everyday preventative measures, such as asking families to keep sick
children at home, reminding staff and students to regularly wash their
hands, and cleaning and disinfecting surface areas. They also
encourage schools to promote vaccinations for the flu and COVID-19,
along with the regular pediatric vaccine schedule.
https://www.k12dive.com/news/how-schools-can-prepare-for-coldand-flu-season/633571/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?
recrs=&cond=Covid19&term=&cntry=&state=&city=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recoveredcovid-19-patients.html

State Updates

New York State Department of Health (DOH)
On October 11, 2022, Governor Hochul updated New Yorkers on the state's progress combating COVID-19. "I urge New
Yorkers to remain vigilant and be sure to use the tools that are available to keep themselves, their loved ones, and their
communities safe and healthy," Governor Hochul said. "Take advantage of the vaccine by staying up to date on doses.
Test before gatherings or travel and if you test positive, talk to your doctor about potential treatment options."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progress-combating-covid-19-360
For a list of COVID-19 positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information regarding testing, cases,
percentages, and fatalities across New York State. It also breaks down cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

Connecticut

On October 7, 2022, Governor Ned Lamont visited a Connecticut Department of Public Health mobile vaccination van clinic in Hartford, where he
was administered a dose of the recently authorized bivalent COVID-19 vaccine booster, which is designed to add protection against the Omicron
variants of the virus and bolster previous vaccination protection. He also received his annual flu shot during the visit.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/10-2022/Governor-Lamont-Receives-Omicron-Bivalent-COVID-19Booster-and-Flu-Shot
The Connecticut Department of Public Health reported that as of October 5, 2022, a total of 283,841 cases of COVID-19 among fully vaccinated
persons in Connecticut have been identified. Those cases account for 10.29% of the 2.7 million people in the state who are fully vaccinated.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/10-2022/Governor-Lamont-Coronavirus-Update-October-6

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
New York City is currently the epicenter of the monkeypox outbreak in the United States. As of October 11, 2022, there are 3,652 cases of monkeypox
in New York City. For the latest information including cases, symptoms, testing, and vaccine information regarding monkeypox in New York City,

please visit https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
NYC DOHMH launched a new COVID-19 variants data page. The data on this page show how variants of the virus that causes COVID-19 are
spreading in NYC. Variants are versions of the virus with certain sets of mutations. Some variants may result in a COVID-19 infection that is easier to
spread, more severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page

Westchester County Department of Health
For the latest breakdown of COVID-19 positive cases in Westchester County as of October 10, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including vaccines for children.
https://health.westchestergov.com/2019-novel-coronavirus
As of October 11, 2022, Westchester County has 89 cases of monkeypox. Monkeypox Vaccine Clinics on Mondays and Wednesdays at 134 Court
Street, White Plains. Appointments are required. People at higher risk for monkeypox infection may consider vaccination with the two-dose JYNNEOS
vaccine. In accordance with CDC guidance, this includes those who:
Had contact with someone who had a rash that looks like monkeypox or with someone who was diagnosed with confirmed or probable
monkeypox
Had skin-to-skin contact with someone in a social network experiencing monkeypox activity; this includes men who have sex with men who
meet partners through an online website, digital application (“app”), or social event such as at a bar or party  
Traveled outside the United States to a country with confirmed cases of monkeypox or where monkeypox activity has been ongoing
Monkeypox Vaccine appointments are also available at:
- Westchester Medical Center, 15 Oval Connector, Valhalla, NY 10595
Monday through Friday from 9 am - 5 pm, appointment required.
Call (914) 326-2060 to schedule an appointment.
For more information regarding monkeypox in Westchester County, please visit
https://health.westchestergov.com/

Putnam County Department of Health
Breakdown of COVID -19 positive cases by towns in Putnam County as of October 7, 2022.
https://www.putnamcountyny.com/covid19/
As of October 11, 2022, there are 5 cases of monkeypox in Putnam County.
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of October 7, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
As of October 11, 2022, there are 10 cases of monkeypox in Dutchess County. For the latest information regarding monkeypox, please visit
https://www.dutchessny.gov/Departments/DBCH/dbch.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of October 11, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
As of October 11, 2022, there are 21 cases of monkeypox in Orange County. For more information regarding monkeypox, please visit
https://www.orangecountygov.com/149/Health

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of October 11, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
As of October 11, 2022, there is 14 cases of monkeypox in Rockland County.
For more information regarding monkeypox, please visit Rockland County Health Department website
https://rocklandgov.com/departments/health/

Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

   
                             Center for Disaster Medicine Media
Faculty News:
Lifesaving STOP THE BLEED Training Can Be the Difference in an Emergency
Westfair
9/26/2022
https://westfaironline.com/wp-content/uploads/2022/09/wf_092622.pdf
George W. Contreras, M.E.P., M.P.H., M.S., CEM, FACEM, assistant director of the Center for Disaster Medicine and assistant professor in the
Institute of Public Health
New Omicron Booster Side Effects Expected to Be Similar to Previous COVID-19 Shots
Healthline
9/21/2022
https://www.healthline.com/health-news/new-omicron-booster-side-effects-expected-to-be-similar-to-previous-covid-19-shots
Marisa A. Montecalvo, M.D., director of Health Services and professor of medicine

Every effort is made to provide accurate and complete information in this newsletter. However, New York Medical College cannot guarantee that
there will be no errors. NYMC makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of the contents of the
newsletters or the articles linked herein and further expressly disclaims liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the advice of your physician or other qualified
health provider with any questions you may have regarding a medical condition.
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